A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease Michael H. RosenbloomTricia O’DonohueThomas J. Grabowski Therapy in Practice Open access 05 June 2024 Pages: 493 - 505
Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives Adrián GuckýSlávka Hamuľaková Review Article Open access 03 June 2024 Pages: 507 - 532
Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy Nazia KarsanPeter J. Goadsby Review Article 31 May 2024 Pages: 533 - 546
Observation on the Analgesic Effect of Different Doses of a Combination of Esketamine and Dexmedetomidine Administered for Percutaneous Endoscopic Transforaminal Discectomy: A Randomized, Double-Blind Controlled Trial Jian-Shun ZhouZhen ChenLi-Feng Wang Original Research Article 04 April 2024 Pages: 547 - 558
Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia Megan GalballyKaren WynterSusanna Every-Palmer Original Research Article Open access 07 May 2024 Pages: 559 - 570
Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics Orwa AlbitarSabariah Noor HarunSiti Maisharah Sheikh Ghadzi Original Research Article 05 June 2024 Pages: 571 - 581